NCT02438202View on ClinicalTrials.gov

Electroconvulsive Therapy for Treatment of Alzheimer´s Disease

NANot yet recruitingINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

December 31, 2026

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions

Alzheimer's Disease

Interventions

DEVICE

Thymatron IV device (Somatics)

Patients will be treated with a modified routine ECT/maintenance ECT series.

All Listed Sponsors

lead

Central Institute of Mental Health, Mannheim

OTHER